Caroline Rahn, research specialist at the Center for Cluster Headache and Department of Neuroscience at Karolinska Institutet, is one of three researchers who will participate in a scholarship worth 200,000 kroner, for a new project where the goal is to investigate comorbidity and mental problems. Disease in migraine patients.
– It is really good that Pfizer and the Swedish Headache Society want to support the research so that we can get started and work on the project, says Caroline Rahn.
From previous research, researchers were able to see that long-term sick leave is more common in headache patients who suffer from multiple diseases.
“Because migraine and headache patients represent a relatively heterogeneous group, we need to gain better knowledge of the risk factors associated with multiple diseases and high disease burden in order to have a holistic approach to patients at risk and to be able to offer better treatment in the future,” explains Caroline Rahn.
A newly established research grant by Pfizer and the Swedish Headache Society aims to promote research that directly benefits migraine patients in Sweden. Between one and three researchers can be awarded a scholarship and the total amount of SEK 200,000 is distributed among the selected projects.
“Extreme tv maven. Beer fanatic. Friendly bacon fan. Communicator. Wannabe travel expert.”
More Stories
Green areas reduce the risk of antidepressant medication withdrawal
Continuous antibiotic treatment in sepsis improves survival
Introducing the requirement of notification for the construction and use of cooling towers